Press "Enter" to skip to content

New patent for Catalyst Pharms drug FIRDAPSE

1
Copyright © DrugPatentWatch. Originally published at New patent for Catalyst Pharms drug FIRDAPSE

Annual Drug Patent Expirations for FIRDAPSE
Annual Drug Patent Expirations for FIRDAPSE

Firdapse is a drug marketed by Catalyst Pharms and is included in one NDA. It is available from one supplier.

The generic ingredient in FIRDAPSE is amifampridine phosphate. One supplier is listed for this compound. Additional details are available on the amifampridine phosphate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent for Catalyst Pharms drug FIRDAPSE
Get the DrugPatentWatch Daily Briefing

✓ Patent Expirations and Generic Entry

✓ Insightful Articles & Case Studies

✓ Patent Litigation & Challenges

✓ 505(b)(2) & Biosimilars

✓ Industry Trends

Do NOT follow this link or you will be banned from the site!